Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, June 2007, p. 2268-2273, Vol. 51, No. 6
0066-4804/07/$08.00+0 doi:10.1128/AAC.01422-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

merová,2
Erik De Clercq,1
Antonin Hol
,2 and
Robert Snoeck1*
Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium,1 Gilead Sciences and IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Centre for New Antivirals and Antineoplastics (IOCB), Flemingovo nám. 2, CZ-166 10, Prague 6, Czech Republic2
Received 14 November 2006/ Returned for modification 1 February 2007/ Accepted 28 March 2007
Murine polyomavirus and simian virus 40 were used to evaluate the potencies of the compounds of three classes of acyclic nucleoside phosphonates: (i) the original HPMP (3-hydroxy-2-phosphonomethoxypropyl) and PME (2-phosphonomethoxyethyl) derivatives, (ii) the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidine (DAPy) derivatives, and (iii) a new class of HPMP derivatives containing a 5-azacytosine moiety. The last class showed the highest activities and selectivities against both polyomaviruses.
Published ahead of print on 9 April 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»